Form 4: Curtiss-Wright Director Acquires Shares

Sentiment:

Insider Transaction Report


Curtiss-Wright Corporation director Larry D. Wyche acquired 128 shares of common stock as part of an annual restricted stock grant.

Summary

  • Director Larry D. Wyche acquired 128 shares of Curtiss-Wright Corporation common stock on February 4, 2026.
  • The shares were granted at a price of $624.93 per share.
  • This acquisition is part of an annual restricted stock grant for non-employee directors under the Company's 2024 Omnibus Incentive Plan.
  • The 128 shares represent 50% of the director's annual restricted stock award, with the remaining 50% (128 shares) deferred to a later date.
  • Following this transaction, Larry D. Wyche beneficially owns 1,514 shares directly.
  • Restrictions on these shares lapse after one year from the grant date or earlier upon cessation of service due to death, disability, or non-reelection.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine director compensation and alignment of interests, without indicating any significant operational or financial changes.

Positives

  • Director share acquisition aligns management interests with shareholders, promoting long-term value creation.
  • The grant is part of a structured incentive plan, indicating sound corporate governance practices for director compensation.

Future Outlook

The restricted shares will vest one year from the grant date (February 4, 2027), or earlier if the director's service ends due to specific circumstances such as death, disability, or failure to be reelected.

Industry Context

StockSavvy.ai notes that restricted stock grants to non-employee directors are a standard practice across many industries, particularly in mature industrial companies like Curtiss-Wright, to align director incentives with long-term shareholder value. This practice is consistent with broader corporate governance trends emphasizing equity-based compensation for board members.

Comparison to Industry Standards

  • The practice of granting restricted stock to non-employee directors is a common compensation strategy, comparable to practices at peers such as General Electric (GE) or Honeywell (HON), which also utilize equity awards to incentivize board members.
  • The vesting period of one year is typical for such grants, ensuring continued commitment from directors.
  • The total annual stock award value of $160,000 for non-employee directors is within the general range observed for directors at companies of similar market capitalization and industry complexity.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation PolicyNon-employee directors receive an annual grant of restricted stock under the 2024 Omnibus Incentive Plan.02/04/2026Reinforces alignment of director interests with shareholders through equity ownership and standardizes director compensation.

Stakeholder Impact

  • Shareholders: Positive impact due to increased alignment of director interests with shareholder value through equity ownership.

Next Steps

  • The acquired restricted shares will vest on February 4, 2027, or earlier under specific conditions.
  • The remaining 50% of the annual restricted stock award (128 shares) will be received by the reporting person at a later, deferred date.

Key Dates

DateDescription
02/04/2026Date of transaction and annual award grant for restricted stock.
02/06/2026Date the Form 4 was signed by Power of Attorney.

Recommendation

hold

This Form 4 filing details a routine, pre-scheduled restricted stock grant to a non-employee director, which is a standard compensation practice. It does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction primarily serves to align director incentives with shareholder interests, which is generally a positive but not a catalyst for a 'buy' or 'sell' decision. Therefore, a 'hold' recommendation is appropriate as this filing does not alter the fundamental investment thesis.

Keywords

Curtiss-Wright, CW, Form 4, Insider Trading, Director Compensation, Restricted Stock, Equity Grant, Beneficial Ownership, SEC Filing, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.